Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study Gut, 60 (2011), pp. 1109-1116 Cross...
Barb D, Kleiner DE, Loomba R. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 M...
Elsevier B.V.Journal of HepatologyEASL Clinical Practice Guidelines: Vascular diseases of the liver . J Hep 2015. In PressEASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016;64:179-202European Association for the Study of the Liver (2016) EASL Clinical Practice ...
So now, moving on to the actual new hep B guidelines. So we started out by defining what are the topics, what are the really important topics and questions. So the first is on expanding treatment eligibility, the viral load threshold, the April score for determining fibrosis using antiviral ...
[7]Europe Medicines Agency. Available at https://www.ema.europa.eu/en/medicines/human/EPAR/hepcludex. Accessed July 2023 [8]Bazinet M, Pântea V, Cebotarescu V, et al. Persistent control of hepatitis B virus and hepatitis delta virus infection following REP 2139‐Ca and pegylated interfe...
1.Qi X, Li J, Caussy C, et al. Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. Hepatology. 2024 May 8. doi: 10.1097/HEP.0000000000000913. Epub ahead of print. ...
在疗效方面,治疗96周时,A组、B组和C组患者联合应答率分别为39%、55%和56%,均较48周时有所提高,此外,在治疗96周时,B组和C组患者无论是在联合应答率还是在ALT复常率上都非常相似(以上具体数据见下表)。在安全性方面,尚未发现与BLV相关的严重不良事件,无患者停药,与接受2mg BLV患者相比,接受10mg BLV患者...
[5] Terrault NA, Lok AS, McMahon BJ, et al. Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018, https://doi.org/10.1002/hep.29800. [6] Harry L.A. Janssen, et al. EASL 2021. PO-2395. ...
[5] Terrault NA, Lok AS, McMahon BJ, et al. Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018, https://doi.org/10.1002/hep.29800. [6] Harry L.A. Janssen, et al. EASL 2021. PO-2395. ...
1.Terrault NA, et al. Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B:AASLD 2018 Hepatitis B Guidance. Hepatology. 2018, https://doi.org/10.1002/hep.29800 2.EASL. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. ...